Cargando…

Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017

BACKGROUND: In the 2016/2017 influenza season, England was in its fourth season of the roll‐out of a live‐attenuated influenza vaccine (LAIV) targeted at healthy children aged two to less than 17 years. For the first time, all healthy children aged 2 to 8 years were offered LAIV at national level in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinnathamby, Mary A., Warburton, Fiona, Andrews, Nick, Boddington, Nicola L., Zhao, Hongxin, Ellis, Joanna, Tessier, Elise, Donati, Matthew, Elliot, Alex J., Hughes, Helen E., Byford, Rachel, Smith, Gillian E., Tripathy, Manasa, de Lusignan, Simon, Zambon, Maria, Pebody, Richard G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692804/ https://www.ncbi.nlm.nih.gov/pubmed/34405555 http://dx.doi.org/10.1111/irv.12898

Ejemplares similares

Influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children in England in the 2015–2016 influenza season – a test-negative case–control study
por: Boddington, N. L., et al.
Publicado: (2019)

Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season
por: Pebody, Richard, et al.
Publicado: (2017)

Rapid influenza molecular testing in secondary care and influenza surveillance in England: Any impact?
por: Boddington, Nicki L., et al.
Publicado: (2022)

Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16
por: Boddington, Nicki L., et al.
Publicado: (2022)

Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17
por: Pebody, Richard G, et al.
Publicado: (2018)

Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
por: Pebody, Richard, et al.
Publicado: (2016)

Impact of General Practitioner Education on Acceptance of an Adjuvanted Seasonal Influenza Vaccine among Older Adults in England
por: de Lusignan, Simon, et al.
Publicado: (2023)

End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17
por: Pebody, Richard, et al.
Publicado: (2017)

An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
por: Sinnathamby, Mary A., et al.
Publicado: (2023)

Serological surveillance of influenza in an English sentinel network: pilot study protocol
por: de Lusignan, Simon, et al.
Publicado: (2019)

Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
por: Sinnathamby, Mary A, et al.
Publicado: (2023)

Mortality Attributable to Influenza in England and Wales Prior to, during and after the 2009 Pandemic
por: Green, Helen K., et al.
Publicado: (2013)

Household presentation of influenza and acute respiratory illnesses to a primary care sentinel network: retrospective database studies (2013–2018)
por: de Lusignan, Simon, et al.
Publicado: (2020)

The impact of social and physical distancing measures on COVID-19 activity in England: findings from a multi-tiered surveillance system
por: Bernal, Jamie Lopez, et al.
Publicado: (2021)

Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
por: Thorrington, Dominic, et al.
Publicado: (2017)

End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18
por: Pebody, Richard, et al.
Publicado: (2019)

Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis
por: Hodgson, David, et al.
Publicado: (2017)

Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: protocol of a pilot study in England
por: de Lusignan, Simon, et al.
Publicado: (2017)

Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card
por: de Lusignan, Simon, et al.
Publicado: (2019)

Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care‐based cohort study
por: Kafatos, George, et al.
Publicado: (2013)

Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza?
por: Dickson, Elizabeth M, et al.
Publicado: (2020)

Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom
por: Jackson, David, et al.
Publicado: (2020)

Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season
por: de Lusignan, Simon, et al.
Publicado: (2020)

Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design
por: Stowe, Julia, et al.
Publicado: (2021)

Integrating molecular point-of-care testing for influenza into primary care: a mixed-methods feasibility study
por: de Lusignan, Simon, et al.
Publicado: (2020)

Influenza and Respiratory Virus Surveillance, Vaccine Uptake, and Effectiveness at a Time of Cocirculating COVID-19: Protocol for the English Primary Care Sentinel System for 2020-2021
por: de Lusignan, Simon, et al.
Publicado: (2021)

Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
por: de Lusignan, Simon, et al.
Publicado: (2021)

Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999–2010
por: Hardelid, P., et al.
Publicado: (2012)

Seroprevalence of Influenza A(H1N1)pdm09 Virus Antibody, England, 2010 and 2011
por: Hoschler, Katja, et al.
Publicado: (2012)

Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation
por: Hill, Edward M., et al.
Publicado: (2020)

Forecasting the 2017/2018 seasonal influenza epidemic in England using multiple dynamic transmission models: a case study
por: Birrell, Paul J., et al.
Publicado: (2020)

Estimating the Population Impact of a New Pediatric Influenza Vaccination Program in England Using Social Media Content
por: Wagner, Moritz, et al.
Publicado: (2017)

Has estimation of numbers of cases of pandemic influenza H1N1 in England in 2009 provided a useful measure of the occurrence of disease?
por: Evans, Barry, et al.
Publicado: (2011)

Enhanced MERS Coronavirus Surveillance of Travelers from the Middle East to England
por: Thomas, Helen Lucy, et al.
Publicado: (2014)

Effect of Pediatric Influenza Vaccination on Antibiotic Resistance, England and Wales
por: Chae, Chungman, et al.
Publicado: (2020)

Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children
por: Turner, P. J., et al.
Publicado: (2019)

Adverse Events of Interest Following Influenza Vaccination in the First Season of Adjuvanted Trivalent Immunization: Retrospective Cohort Study
por: de Lusignan, Simon, et al.
Publicado: (2022)

Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis
por: de Lusignan, Simon, et al.
Publicado: (2018)

The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment
por: Zhang, Xu-Sheng, et al.
Publicado: (2014)

Developing influenza and respiratory syncytial virus activity thresholds for syndromic surveillance in England
por: Harcourt, S. E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9v4ma48v4pkuil1uef8k1mvg4a